by Eamonn | Jul 8, 2021 | News
Ribavirin is the only available Lassa fever–specific treatment and has been used routinely for over 25 years. However, Ribavirin is not licensed for Lassa fever, its mechanism of action is unclear, it’s expensive and hard to source, and it has well-known...
by Eamonn | Mar 24, 2021 | News
Women under 50 and people who experienced severe disease had worse long-term outcomes following hospitalisation with COVID-19. The first long-term follow-up data from the International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) Clinical...
by Eamonn | Mar 10, 2021 | News
In the largest study of its kind to date, the UK’s International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC), supported by the UK Coronavirus Immunology Consortium (UK-CIC), has identified new biomarkers of inflammation that both indicate the...
by Eamonn | Feb 15, 2021 | News, Uncategorised
The Lancet Infectious Diseases published the GloPID-R and ISARIC Long COVID Forum Working Group’ letter, describing the content and discussions of the Long COVID Forum which took place on 9-10 December 2020. This global public forum, organised by ISARIC, GloPID-R and...
by Eamonn | Jan 18, 2021 | Uncategorised
Study conducted in Iran where the data was retrospectively and prospectively collected. The Case report form (CRF) was mainly based on ISARIC’s CRF. A web-based, 2-language software was also developed to facilitate data collection and storage. The organisation...
